Name: 글로벌 시장 동향
SKU: PH4908
Availability: InStock

보고서 요약(국문)

시장 개요
의약품 좌약 시장은 2023년부터 2030년까지 예측 기간 동안 연평균 성장률(CAGR) 4.40%에 도달할 것으로 예상됩니다.
좌약은 구강 이외의 신체 부위에 삽입하도록 특별히 고안된 고형 약물 제형입니다. 직장, 질, 요도 등 다양한 부위에 삽입할 수 있습니다. 삽입 후, 좌약은 체액에 녹아 약물을 방출합니다. 좌약은 삽입 부위에 따라 직장 좌약, 질 좌약, 요도 좌약으로 분류됩니다. 좌약은 국소 작용을 촉진하며, 약물의 대사를 막는 초회 통과 효과(first-pass effect)가 없습니다. 쓴맛이 나거나 불쾌한 약물의 경우, 좌약은 약물 전달 방법으로 사용될 수 있습니다. 좌약은 소아과에서 변비와 유사한 증상을 완화하는 데 자주 사용됩니다.

의약품 좌약 시장 동향
선진국의 의료비 지출 증가와 고령 인구 증가는 의약품 좌약 시장 성장을 견인하는 요인입니다. 직장 투여 방식은 이러한 인구 집단에서 효과적인 약물 전달 수단입니다. 다양한 저분자량 약물의 빠른 흡수 및 림프계 흡수 가능성 등의 이점으로 인해 좌약에 대한 수요가 증가하고 있으며, 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.
고령 인구 증가가 시장 성장을 견인할 것입니다.
세계 인구 중 60세 이상 인구 비율은 2015년 12%에서 2050년 22%로 거의 두 배 증가할 것으로 예상됩니다. 2023년에는 60세 이상 인구가 5세 미만 아동 인구를 넘어설 것입니다. 2050년에는 세계 고령 인구의 80%가 저소득 및 중소득 국가에 거주할 것으로 예상됩니다. 현재 인구 고령화 속도는 과거보다 훨씬 빠릅니다. (출처: 세계보건기구) 따라서 감염성 질환에 더 취약한 환자들은 좌약 시장의 성장을 촉진할 것으로 예상됩니다.
또한, 다양한 저분자량 약물의 빠른 흡수 및 림프계 흡수 가능성과 같은 이점 덕분에 좌약에 대한 수요 증가가 향후 시장 성장을 견인할 것으로 전망됩니다. 더 나아가, 좌약은 물리적, 화학적 안정성이 우수하고 점막에 대한 중성, 그리고 거의 모든 활성 성분과의 완벽한 호환성을 가지고 있어 전 세계 좌약 시장의 성장에 기여할 것으로 예측됩니다.
하지만 개발도상국의 낮은 수요는 시장 성장을 저해할 가능성이 있습니다.
개발도상국에서는 연구 개발 지출이 주로 외부 자금 지원에 의존합니다. 정부와 민간 기관이 연구 프로그램에 자금을 지원하려고 노력하지만, 많은 연구 기관과 학술 기관은 예산 제약에 직면해 있습니다. 이들은 첨단 고가의 장비와 기술을 구매할 여력이 없어 이러한 산업의 성장과 개발도상국에서의 확장에 걸림돌이 됩니다.

COVID-19 영향 분석
2020년 12월 말, 중국 후베이성 우한에서 코로나바이러스(COVID-19)가 발견되었습니다. 이 질병은 SARS-CoV-2(중증급성호흡기증후군 코로나바이러스 2)에 의해 발생하며, 사람 간 전염됩니다. COVID-19는 원자재 유통망의 중단으로 인해 2020년 의약품 좌약 생산에 차질을 빚었습니다. 더욱이, 봉쇄 조치로 인해 제조 공장에 필요한 인력이 격리 또는 자가격리에 투입되면서 주요 제조 공장들이 가동을 중단하게 되었습니다. 유통망 차질로 인해 제약 업계는 재정난, 인력 부족, 수요와 공급 불균형 심화 등의 문제를 겪었으며, COVID-19 팬데믹은 의약품 좌약 시장에 전반적으로 부정적인 영향을 미쳤습니다.

제약 좌약 시장 세그먼트 분석
직장 좌약 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
시장은 요도 좌약, 직장 좌약, 질 좌약으로 구분됩니다. 2020년에는 직장 좌약이 가장 많은 매출을 올렸습니다. 이는 직장 좌약 개발에 대한 투자가 증가했기 때문입니다. 시장 성장에 영향을 미치는 주요 요인으로는 치질 및 변비와 같은 질환의 유병률 증가와 직장 좌약 제조업체의 투자 증가가 있습니다. 또한, 고령 인구 증가와 좌약 제형에 대한 수요 증가는 기업들이 제약 좌약 개발에 집중하도록 유도했습니다.
HD 치료 센터에 따르면, 미국인의 약 절반이 50세 이전에 치질을 앓고 있으며, 그중 치료를 받는 사람은 소수에 불과합니다. 미국에서는 약 1,040만 명이 치질을 앓고 있으며, 매년 100만 건의 새로운 사례가 진단됩니다. 신규 환자의 10~20%는 수술이 필요합니다. 치질은 나이와 관련이 있는 것으로 알려져 있으며, 나이가 들수록 치질 발생 가능성이 높아집니다. 치질은 30세 이상에서 가장 흔하게 발생하지만, 모든 연령대에서 발생할 수 있습니다. 이러한 요인들이 해당 시장의 성장을 견인하고 있습니다.
의약품 좌약 시장 지역 분석
북미 지역은 전 세계 의약품 좌약 시장에서 가장 큰 시장 점유율을 차지합니다.
북미는 잘 발달된 의료 산업, 주요 제조업체의 존재, 높은 좌약 사용률로 인해 의약품 좌약 시장 매출에서 상당한 비중을 차지할 것입니다. 또한, 노령 인구 증가, 변비 및 치질 환자 수 증가, 그리고 의료 인프라 개선이 성장 요인으로 작용하고 있습니다. 또한, 미국은 의료 시설 및 연구에 대한 세계 최대 지출국으로 널리 알려져 있습니다. 예측 기간 동안 위에서 언급한 요인들이 의약품 좌약 시장의 성장에 기여할 것입니다.
아시아 태평양 지역은 두 번째로 큰 시장 점유율을 차지하고 있습니다. 기술 개발 외에도 의약품 좌약 서비스 부문은 연구 예측 기간 동안 놀라운 속도로 성장할 것으로 예상됩니다. 위에서 언급한 지역 외에도 유럽과 남미는 연구 기간 동안 전 세계 의약품 좌약 시장에서 상당한 시장 점유율을 차지했습니다.
의약품 좌약 시장 경쟁 환경
의약품 좌약 시장은 여러 주요 업체들이 경쟁하는 치열한 시장입니다. 현재 몇몇 대기업이 시장 점유율 측면에서 시장을 장악하고 있습니다. 여러 기업들이 독창적이고 정교한 치료제를 개발하기 위해 연구 개발에 투자하고 있는 것으로 확인되었습니다. 시장 성장에 기여하는 주요 기업으로는 Pfizer Inc, Bliss Gvs Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight UK Ltd, Glenmark Pharmaceuticals Limited, Cosette Pharmaceuticals Inc, Intas Pharmaceuticals Ltd, Novartis International AG, Sanofi 등이 있습니다. 주요 기업들은 신제품 출시, 인수, 협력 등 다양한 성장 전략을 통해 전 세계 좌약 시장의 성장을 견인하고 있습니다. 예를 들어, 2020년 2월 Zydus Cadila는 미국 식품의약국(FDA)으로부터 메살라민 좌약 판매 승인을 받았습니다.
주요 동향
2019년 11월, 주로 국소 및 좌약 제품에 주력하는 제네릭 제약 회사인 Cosette Pharmaceuticals, Inc.는 Migergot®(에르고타민 타르트레이트 및 카페인 좌약)을 미국에서 상용화할 것이라고 발표했습니다.

블리스 GVS 파마슈티컬스(Bliss GVS Pharmaceuticals Ltd)
개요: 블리스 GVS 파마슈티컬스는 인도에 설립된 제약 회사입니다. 이 회사는 의약품을 제조, 판매, 유통 및 수출합니다. 매출의 대부분은 인도 외 지역에서 발생합니다. 로나트(Lonart), P-알락신(P-Alaxin), 펀박트(Funbact), 로프낙(Lofnac) 등이 이 회사의 브랜드입니다. 정제, 현탁액, 좌약, 주사제 등 다양한 의약품을 제공합니다.
제품 포트폴리오:
아노멕스 좌약: 항문열상 및 치질 치료에 사용되는 아노멕스 좌약은 여러 약물이 복합된 처방약입니다. 발적, 자극, 부종 및 알레르기 반응을 완화하고 통증을 줄여줍니다.

보고서 요약(영어 원문)

Market Overview
Pharmaceutical Suppositories Market is estimated to reach at a compound annual growth rate (CAGR) of 4.40% over the forecast period 2023 to 2030.
Suppositories are solid drug dosage forms specifically designed for insertion into bodily cavities other than the mouth. They can be inserted into the rectum, vaginal canal, or urethra, among other places. Following implantation, these things are meant to melt or dissolve in the cavity fluids, releasing the medicine. Suppositories are classified as a rectal suppository, vaginal suppository, or urethral suppository, depending on where they are inserted. Suppositories can help with site action. It does not include the first-pass effect, which protects the medication from metabolism. In the case of bitter or disagreeable medications, suppositories might be utilized as a drug delivery method. Suppositories are frequently used in pediatrics to alleviate constipation-like symptoms.
Pharmaceutical Suppositories Market Dynamics
Increasing expenditure on the healthcare sector in developed countries and the geriatric population drives the pharmaceutical suppositories market. The rectal route is an excellent drug delivery option in these populations. Due to benefits such as quick absorption of various low molecular weight drugs and the potential for absorption into the lymphatic system, increased demand for suppositories is expected to boost market growth during the forecasted period.
The increase in the geriatric population in the market will drive the market growth
The fraction of the world's population aged 60 and up will nearly double from 12 percent to 22 percent between 2015 and 2050. By 2023, the number of persons aged 60 and more will outweigh youngsters under five. By 2050, 80% of the world's elderly will live in low- and middle-income countries. The population is aging at a considerably higher rate than in the past. (Source: World Health Organization). Thus, they are more likely to be prone by infectious diseases which will boost the pharmaceutical suppositories market.
Moreover, due to benefits such as fast absorption of various low molecular weight medications and the possibility for absorption into the lymphatic system, growing demand for suppositories is expected to boost market growth over the anticipated period. Furthermore, the suppositories industry is predicted to increase due to better physical and chemical stability, neutrality toward mucosal membranes, and full compatibility with virtually all active substances.This contributes to the growth of the global pharmaceutical suppositories market.
Low demand in underdeveloped countries is likely to hamper the market growth
In developing economies, research and development spending primarily rely on funding from outside sources. Although governments and private bodies try to fund research programs, many research firms and academic institutes face budget constraints. They cannot afford advanced and high-priced equipment and technologies, which harms the growth of these industries and their expansion in developing countries.
COVID-19 Impact Analysis
In late December, the Coronavirus (COVID-19) was found in Wuhan, Hubei Province, China. The condition is caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is spread from person to person. COVID-19 disrupted the production of pharmaceutical suppositories in 2020 due to a halt in the raw material distribution chain. Furthermore, lockdown diverted the staff required for manufacturing factories to house quarantine or lockdown, resulting in the major manufacturing plants being shut down. Due to disruption in the distribution chain, the pharmaceutical sector recorded financial troubles, labor scarcity, and an increase in the demand and supply imbalance, the overall impact of the COVID-19 pandemic on the pharmaceutical suppositories market as unfavorable.
Pharmaceutical Suppositories Market Segment Analysis
The rectal suppository segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The market is divided into urethral suppositories, rectal suppositories and vaginal suppositories. In 2020, the rectal suppository generated the most revenue. This is due to a greater emphasis on the development of rectal suppository. Major factors influencing the market growth include an increase in the prevalence of diseases such as hemorrhoids and constipation and an increase in investments by rectal suppositories manufacturers. Furthermore, the growing geriatric population and the increased demand for suppositories dosage forms have influenced companies to focus on the development of pharmaceutical suppositories.
According to the HD Treatment Center, roughly half of all Americans have hemorrhoids by 50, and only a small percentage of those people seek treatment. Hemorrhoids affect roughly 10.4 million people in the United States, with 1 million new cases diagnosed each year. Surgery is required in 10% to 20% of new cases. Hemorrhoids are believed to be influenced by age, with the likelihood of hemorrhoids increasing as a person gets older. Hemorrhoids most commonly affect people over the age of 30; however, they can affect anyone at any age. These factors are driving the growth of this segment.
Pharmaceutical Suppositories Market Geographical Analysis
North America region holds the largest market share of global pharmaceutical suppositories market
North America will account for the significant share in terms of revenue of the pharmaceutical suppositories market because of the region's well-developed healthcare industry, presence of top manufacturers, and high suppositories adoption rate. Moreover, there is an increase in geriatrics, a rise in the number of people suffering from constipation and hemorrhoids, and an improvement in the region's healthcare infrastructure. Furthermore, the United States is widely regarded as the world's top spender on healthcare facilities and research. During the projected period, the reasons mentioned above will contribute to the growth of the pharmaceutical suppositories market.
The Asia Pacific area has the second-largest market share. Aside from technology developments, the pharmaceutical suppositories service category is predicted to increase at a phenomenal rate over the study's forecast period. In addition to the areas mentioned above, Europe and South America held a significant market share in the worldwide pharmaceutical suppositories market throughout the study period.
Pharmaceutical Suppositories Market Competitive Landscape
The pharmaceutical suppositories market is fiercely competitive, with several main players. Few big firms currently dominate the market in terms of market share. Several companies have been identified to be investing in their R&D to develop unique and sophisticated therapeutic medications. Some of the key players which are contributing to the growth of the market include Pfizer Inc, Bliss Gvs Pharma Ltd, Cadila Healthcare Ltd, Church And Dwight UK Ltd, Glenmark Pharmaceuticals Limited, Cosette Pharmaceuticals Inc, Intas Pharmaceuticals Ltd, Novartis International AG, Sanofi. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the pharmaceutical suppositories market globally. For instance Februray 2020, Zydus Cadila receives approval from the United States Food and drug administration to market Mesalamine suppositories.
Key Developments
In November 2019, Cosette Pharmaceuticals, Inc., a generic pharmaceutical company focused primarily on extended topical and suppository products, announced that it would commercialize Migergot® (ergotamine tartrate and caffeine suppositories) in the United States.
Bliss GVS Pharmaceuticals Ltd
Overview: Bliss GVS Pharma Ltd is a pharmaceutical firm established in India. Pharmaceutical items are manufactured, marketed, traded, and exported by the company. Outside of India accounts for the majority of its revenue. Lonart, P-Alaxin, Funbact, and Lofnac, among others, are some of the company's brands. Tablets, suspensions, suppositories, and injections are among the pharmaceutical goods available.
Product Portfolio:
Anomex Suppository: Anal fissures and hemorrhoids are treated with Anomex Suppository, a prescription treatment that contains a combination of medications. It relieves redness, irritation, edema, and allergic responses. It also reduces the sensation of pain.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Type
3.2. Market snippet by Base
3.3. Market snippet by End User
3.4. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in geriatric population.
4.1.1.2. Increasing government funding for healthcare.
4.1.2. Restraints:
4.1.2.1. Low demand in underdeveloped countries.
4.1.3. Side effects caused by the use of suppositories
4.1.4. Opportunity
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
7.1.2. Market Attractiveness Index, By Type Segment
7.2. Rectal Suppositories*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2022-2029
7.3. Vaginal Suppositories
7.4. Urethral Suppositories
8. By Base
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Base
8.1.2. Market Attractiveness Index, By Base
8.2. Fatty Base*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2022-2029
8.3. Water Miscible Bases
8.4. Emulsifying Bases
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User Segment
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2022-2029
9.3. Clinics
9.4. Home Care
9.5. Nursing Home
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2022-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Base
10.2.5. Market Size Analysis ,and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Base
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By End User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Base
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Base
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Base
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. Key Companies to Watch
12. Company Profiles
12.1. Bliss GVS Pharma Ltd*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Pfizer Inc
12.3. Cadila Healthcare Ltd
12.4. Church And Dwight UK Ltd
12.5. Glenmark Pharmaceuticals Limited
12.6. Cosette Pharmaceuticals Inc
12.7. Intas Pharmaceuticals Ltd
12.8. Novartis International AG
12.9. Sanofi SA(*LIST NOT EXHAUSTIVE)
13. DataM Intelligence
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Bliss GVS Pharma Ltd, Pfizer Inc, Cadila Healthcare Ltd, Church And Dwight UK Ltd, Glenmark Pharmaceuticals Limited, Cosette Pharmaceuticals Inc, Intas Pharmaceuticals Ltd, Novartis International AG

표 목록 (Tables)

List of Tables Table 1 Global Pharmaceutical Suppositories Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Pharmaceutical Suppositories Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Pharmaceutical Suppositories Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Pharmaceutical Suppositories Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Pharmaceutical Suppositories Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 7 Global Pharmaceutical Suppositories Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 8 Global Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 9 Global Pharmaceutical Suppositories Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 10 Global Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 11 Global Pharmaceutical Suppositories Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 12 Global Pharmaceutical Suppositories Market Value, By Region, 2022-2033 (US$ Billion)

Table 13 North America Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 14 North America Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 15 North America Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 16 North America Pharmaceutical Suppositories Market Value, By Country, 2022-2033 (US$ Billion)

Table 17 Europe Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 18 Europe Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 Europe Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 Europe Pharmaceutical Suppositories Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Pharmaceutical Suppositories Market Value, By Country, 2022-2033 (US$ Billion)

Table 25 South America Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 26 South America Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 27 South America Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 28 South America Pharmaceutical Suppositories Market Value, By Country, 2022-2033 (US$ Billion)

Table 29 Middle East and Africa Pharmaceutical Suppositories Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 30 Middle East and Africa Pharmaceutical Suppositories Market Value, By Application, 2022-2033 (US$ Billion)

Table 31 Middle East and Africa Pharmaceutical Suppositories Market Value, By End-User, 2022-2033 (US$ Billion)

Table 32 Middle East and Africa Pharmaceutical Suppositories Market Value, By Country, 2022-2033 (US$ Billion)

Table 33 Sanofi: Overview

Table 34 Sanofi: Product Portfolio

Table 35 Sanofi: Key Developments

Table 36 Haleon Group: Overview

Table 37 Haleon Group: Product Portfolio

Table 38 Haleon Group: Key Developments

Table 39 Church & Dwight Co., Inc.: Overview

Table 40 Church & Dwight Co., Inc.: Product Portfolio

Table 41 Church & Dwight Co., Inc.: Key Developments

Table 42 Teva Pharmaceuticals USA, Inc.: Overview

Table 43 Teva Pharmaceuticals USA, Inc.: Product Portfolio

Table 44 Teva Pharmaceuticals USA, Inc.: Key Developments

Table 45 Zydus Cadila: Overview

Table 46 Zydus Cadila: Product Portfolio

Table 47 Zydus Cadila: Key Developments

Table 48 Camber Pharmaceuticals, Inc.: Overview

Table 49 Camber Pharmaceuticals, Inc.: Product Portfolio

Table 50 Camber Pharmaceuticals, Inc.: Key Developments

Table 51 Prestige Consumer Healthcare Inc.: Overview

Table 52 Prestige Consumer Healthcare Inc.: Product Portfolio

Table 53 Prestige Consumer Healthcare Inc.: Key Developments

Table 54 Typharm Group: Overview

Table 55 Typharm Group: Product Portfolio

Table 56 Typharm Group: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 4 Global Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 5 Global Pharmaceutical Suppositories Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Pharmaceutical Suppositories Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 7 Rectal Suppositories Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 8 Vaginal Suppositories Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 9 Urethral Suppositories Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 10 Global Pharmaceutical Suppositories Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 11 Gastrointestinal Application in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 12 Hemorrhoids Application in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 13 Vaginal Candidiasis Application in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 14 Fever Application in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 15 Others Application in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 16 Global Pharmaceutical Suppositories Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 17 Hospitals & Clinics End-User in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 18 Nursing Homes End-User in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 19 Homecare Settings End-User in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 20 Others End-User in Global Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 21 Global Pharmaceutical Suppositories Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 22 North America Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 23 North America Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 24 North America Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 25 North America Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 26 North America Pharmaceutical Suppositories Market Share, By Country, 2024 & 2033 (%)

Figure 27 Europe Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 28 Europe Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 29 Europe Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 30 Europe Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 31 Europe Pharmaceutical Suppositories Market Share, By Country, 2024 & 2033 (%)

Figure 32 Asia-Pacific Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 33 Asia-Pacific Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 34 Asia-Pacific Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 35 Asia-Pacific Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 36 Asia-Pacific Pharmaceutical Suppositories Market Share, By Country, 2024 & 2033 (%)

Figure 37 South America Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 38 South America Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 39 South America Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 40 South America Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 41 South America Pharmaceutical Suppositories Market Share, By Country, 2024 & 2033 (%)

Figure 42 Middle East and Africa Pharmaceutical Suppositories Market Value, 2022-2033 (US$ Billion)

Figure 43 Middle East and Africa Pharmaceutical Suppositories Market Share, By Product Type, 2024 & 2033 (%)

Figure 44 Middle East and Africa Pharmaceutical Suppositories Market Share, By Application, 2024 & 2033 (%)

Figure 45 Middle East and Africa Pharmaceutical Suppositories Market Share, By End-User, 2024 & 2033 (%)

Figure 46 Sanofi: Financials

Figure 47 Haleon Group: Financials

Figure 48 Church & Dwight Co., Inc.: Financials

Figure 49 Teva Pharmaceuticals USA, Inc.: Financials

Figure 50 Zydus Cadila: Financials

Figure 51 Camber Pharmaceuticals, Inc.: Financials

Figure 52 Prestige Consumer Healthcare Inc.: Financials

Figure 53 Typharm Group: Financials